EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease

Michelle Temby, Theresa L Boye, Jacqueline Hoang, Ole H Nielsen iD, John Gubatan iD

Biomolecules · 2023

DOI: 10.3390/biom13111620 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Michelle Temby und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305-5101, USA. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Chan Zuckerberg Biohub Physician Scientist Scholar Award, NIH NIDDK LRP Award, Doris Duke Physician Scientist Fellowship Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is a known complication of chronic inflammation of the colon (“colitis-associated colon cancer”). Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract. Patients with IBD are at increased risk of colon cancer compared to the general population. Kinase signaling pathways play critical roles in both the inflammation and regulating cellular processes such as proliferation and survival that contribute to cancer development. Here we review the interplay of kinase signaling pathways (mitogen-activated protein kinases, cyclin-dependent kinases, autophagy-activated kinases, JAK-STAT, and other kinases) and their effects on colitis-associated colon cancer. We also discuss the role of JAK-STAT signaling in the pathogenesis of IBD and the therapeutic landscape of JAK inhibitors for the treatment of IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis-Associated NeoplasmsInflammatory Bowel DiseasesHumansJanus KinasesInflammation

Stichwörter der Autor:innen

Crohn’s diseaseJAK inhibitorcolon cancerinflammationinflammatory bowel diseasekinaseulcerative colitis

Substanzen

Janus Kinases

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305-5101, USA.
  • Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, 2730 Herlev, Denmark.

ORCID-Profile: Ole H Nielsen, John Gubatan

Förderung

  • NIDDK NIH HHS
  • Chan Zuckerberg Biohub Physician Scientist Scholar Award, NIH NIDDK LRP Award
  • Doris Duke Physician Scientist Fellowship Award
  • Stanford MCHRI Pediatric IBD and Celiac Disease Research Award

Zitieren

APA

Temby, M., Boye, T. L., Hoang, J., Nielsen, O. H., & Gubatan, J. (2023). Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease. Biomolecules. https://doi.org/10.3390/biom13111620

Vancouver

Temby M, Boye TL, Hoang J, Nielsen OH, Gubatan J. Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease. Biomolecules. 2023. doi:10.3390/biom13111620

BibTeX
@article{Temby2023,
  author = {Temby, Michelle and Boye, Theresa L and Hoang, Jacqueline and Nielsen, Ole H and Gubatan, John},
  title = {Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13111620}
}
Kostenlos starten →